Pfizer Inc. (PFE)

PFE (NYSE:Pharmaceuticals: Major) EQUITY
$37.53
pos +0.00
+0.00%
Today's Range: 37.22 - 37.59 | PFE Avg Daily Volume: 20,013,800
Last Update: 07/13/18 - 4:02 PM EDT
Volume: 0
YTD Performance: 3.62%
Open: $0.00
Previous Close: $37.52
52 Week Range: $32.32 - $39.43
Oustanding Shares: 5,849,571,000
Market Cap: 219,475,906,250
6-Month Chart
TheStreet Ratings Grade for PFE
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 6 6
Moderate Buy 1 1 1 1
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 1 1
Mean Rec. 1.59 1.59 1.95 1.95
Latest Dividend: 0.34
Latest Dividend Yield: 3.62%
Dividend Ex-Date: 08/02/18
Price Earnings Ratio: 10.42
Price Earnings Comparisons:
PFE Sector Avg. S&P 500
10.42 10.36 20.10
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
3.33% 12.77% 7.78%
GROWTH 12 Mo 3 Yr CAGR
Revenue -0.53 0.10 0.02
Net Income 202.42 1.30 0.32
EPS 200.85 1.50 0.35
Earnings for PFE:
EBITDA 20.69B
Revenue 52.55B
Average Earnings Estimates
Qtr (06/18) Qtr (09/18) FY (12/18) FY (12/19)
Average Estimate $0.75 $0.77 $2.96 $3.06
Number of Analysts 6 4 9 9
High Estimate $0.77 $0.79 $3.01 $3.13
Low Estimate $0.73 $0.75 $2.91 $3.03
Prior Year $0.67 $0.67 $2.65 $2.96
Growth Rate (Year over Year) 11.69% 14.55% 11.66% 3.49%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
For Pfizer, China is third largest market and a growing area of concern.
We believe the company has double-digit total return potential at its current price.
Pfizer reorganization could pave way for the company to spin off businesses.
The stock faces a lot of headwinds on a day when markets are trying to surmount trade-war woes.
The bets are coming off one table and going to another amid the tariff news, much to the consternation of the sideliners.

More From the Tweeter in Chief Real Money Pro($)

Stocks are off of their day's highs, and Pfizer (PFE) has pulled back on a Trump tweet:
A bullish strategy for traders of PFE stock.
The seemingly terrific rationales for strength in these economically sensitive sectors seem glib until the bigger global economic issues get resolved.
Bullish
Jun 08, 2018 | 8:28 AM EDT
Pfizer (PFE) was rated 'New Overweight' at Cantor with a $45 price target.
Options spreads aren't tradable with some small biotechs, making shares the only way to play.

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

COLUMNIST TWEETS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.